Latest News

Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI
Read More
[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.
Read More
Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods
Read More